Health Care & Life Sciences » Biotechnology | Regen BioPharma Inc.

Regen BioPharma Inc.

Regen BioPharma Inc. Non-Cum. Pfd. Series A
Stock Exchange Other OTC
EPS
-
Market Cap
-
Shares Outstanding
140.43 M
Public Float
99.06 M
Regen BioPharma Inc.
Stock Exchange OTCBB
EPS
$0.01
Market Cap
$225.2 K
Shares Outstanding
281.51 M
Public Float
247.99 M

Profile

Address
4700 Spring Street
La Mesa California 91942
United States
Employees -
Website http://www.regenbiopharmainc.com
Updated 07/08/2019
Regen Biopharma, Inc. engages in the development of regenerative medical applications licensed from other companies. It plans to develop advance novel technologies through pre-clinical, and Phase I and II clinical trials. The company was founded on April 24, 2012 and is headquartered in La Mesa, CA.

Financials

View All

David Raymond Koos
Chairman, CEO, Secretary & Treasurer
Todd S. Caven
Chief Financial Officer